IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment

Alfredo Perales-Puchalta Vaccine and Immunotherapy Center, The Wistar Institute, Philadlephia, PA, USA

Nikolaos Svoronosb Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PAView further author information

Daniel O. Villarrealc Department of Pathology, University of Pennsylvania, Philadelphia, PAUSA;d Oncology Discovery, Janssen R&D, Spring House, PA, USAView further author information

Urvi Zankhariaa Vaccine and Immunotherapy Center, The Wistar Institute, Philadlephia, PA, USAView further author information

Emma Reuschela Vaccine and Immunotherapy Center, The Wistar Institute, Philadlephia, PA, USAView further author information

Krzysztof Wojtaka Vaccine and Immunotherapy Center, The Wistar Institute, Philadlephia, PA, USAView further author information

Kyle K. Paynee Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FLUSAView further author information

Elizabeth K. Duperreta Vaccine and Immunotherapy Center, The Wistar Institute, Philadlephia, PA, USA

Kar Muthumania Vaccine and Immunotherapy Center, The Wistar Institute, Philadlephia, PA, USAView further author information

Jose R. Conejo-Garciae Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FLUSAView further author information

David B. Weinera Vaccine and Immunotherapy Center, The Wistar Institute, Philadlephia, PA, USACorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window